Ilex Medical Statistics

Total Valuation

Ilex Medical has a market cap or net worth of ILS 685.16 million. The enterprise value is 511.98 million.

Market Cap	685.16M
Enterprise Value	511.98M

Important Dates

The last earnings date was Tuesday, May 27, 2025.

Earnings Date	May 27, 2025
Ex-Dividend Date	Apr 7, 2025

Share Statistics

Ilex Medical has 11.19 million shares outstanding. The number of shares has increased by 0.25% in one year.

Current Share Class	11.19M
Shares Outstanding	11.19M
Shares Change (YoY)	+0.25%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	62.77%
Owned by Institutions (%)	12.84%
Float	2.85M

Valuation Ratios

The trailing PE ratio is 17.48.

PE Ratio	17.48
Forward PE	n/a
PS Ratio	0.74
PB Ratio	1.06
P/TBV Ratio	1.10
P/FCF Ratio	20.47
P/OCF Ratio	11.60
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.50, with an EV/FCF ratio of 15.29.

EV / Earnings	14.98
EV / Sales	0.56
EV / EBITDA	5.50
EV / EBIT	10.42
EV / FCF	15.29

Financial Position

The company has a current ratio of 2.60, with a Debt / Equity ratio of 0.08.

Current Ratio	2.60
Quick Ratio	1.86
Debt / Equity	0.08
Debt / EBITDA	0.49
Debt / FCF	1.47
Interest Coverage	22.35

Financial Efficiency

Return on equity (ROE) is 6.20% and return on invested capital (ROIC) is 5.22%.

Return on Equity (ROE)	6.20%
Return on Assets (ROA)	3.59%
Return on Invested Capital (ROIC)	5.22%
Return on Capital Employed (ROCE)	7.94%
Revenue Per Employee	5.18M
Profits Per Employee	191,966
Employee Count	178
Asset Turnover	0.93
Inventory Turnover	4.44

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.07% in the last 52 weeks. The beta is 0.05, so Ilex Medical's price volatility has been lower than the market average.

Beta (5Y)	0.05
52-Week Price Change	-8.07%
50-Day Moving Average	6,192.24
200-Day Moving Average	6,838.88
Relative Strength Index (RSI)	46.60
Average Volume (20 Days)	2,523

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ilex Medical had revenue of ILS 922.08 million and earned 34.17 million in profits. Earnings per share was 3.05.

Revenue	922.08M
Gross Profit	215.11M
Operating Income	57.08M
Pretax Income	54.76M
Net Income	34.17M
EBITDA	87.34M
EBIT	57.08M
Earnings Per Share (EPS)	3.05

Full Income Statement

Balance Sheet

The company has 222.51 million in cash and 49.33 million in debt, giving a net cash position of 173.18 million or 15.48 per share.

Cash & Cash Equivalents	222.51M
Total Debt	49.33M
Net Cash	173.18M
Net Cash Per Share	15.48
Equity (Book Value)	646.41M
Book Value Per Share	57.47
Working Capital	428.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 59.04 million and capital expenditures -25.56 million, giving a free cash flow of 33.48 million.

Operating Cash Flow	59.04M
Capital Expenditures	-25.56M
Free Cash Flow	33.48M
FCF Per Share	2.99

Full Cash Flow Statement

Margins

Gross margin is 23.33%, with operating and profit margins of 6.19% and 3.71%.

Gross Margin	23.33%
Operating Margin	6.19%
Pretax Margin	5.94%
Profit Margin	3.71%
EBITDA Margin	9.47%
EBIT Margin	6.19%
FCF Margin	3.63%

Dividends & Yields

This stock pays an annual dividend of 1.22, which amounts to a dividend yield of 1.99%.

Dividend Per Share	1.22
Dividend Yield	1.99%
Dividend Growth (YoY)	-10.63%
Years of Dividend Growth	n/a
Payout Ratio	44.68%
Buyback Yield	-0.25%
Shareholder Yield	1.75%
Earnings Yield	4.99%
FCF Yield	4.89%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 21, 2000. It was a forward split with a ratio of 9.

Last Split Date	Aug 21, 2000
Split Type	Forward
Split Ratio	9

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a